NPPB and familial dilated cardiomyopathy: Following admission, symptomatic therapy combined with immunoadsorption resulted in marked clinical improvement, reflected by a decline in BNP levels and partial recovery of LVEF, suggesting therapeutic benefit from this approach in advanced DCM.